James Gordon

Stock Analyst at JP Morgan

(2.96)

# 1,581

Out of 4,761 analysts

7

Total ratings

100%

Success rate

28.86%

Average return

Main Sectors:

Top Industries:

Stocks Rated by James Gordon

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ARGX argenx SE	Maintains: Overweight	$640 → $670	$644.48	+3.96%	5	Nov 4, 2024
	GMAB Genmab	Downgrades: Neutral	n/a	$22.34	-	1	Aug 20, 2024
	FGEN FibroGen	Upgrades: Neutral	n/a	$0.71	-	1	Apr 7, 2021

argenx SE

Nov 4, 2024

Maintains: Overweight

Price Target: $640 → $670

Current: $644.48

Upside: +3.96%

Genmab

Aug 20, 2024

Downgrades: Neutral

Price Target: n/a

Current: $22.34

Upside: -

FibroGen

Apr 7, 2021

Upgrades: Neutral

Price Target: n/a

Current: $0.71

Upside: -